These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 39456247)

  • 1. Some Glycoproteins Expressed on the Surface of Immune Cells and Cytokine Plasma Levels Can Be Used as Potential Biomarkers in Patients with Colorectal Cancer.
    Batsalova T; Uzunova D; Chavdarova G; Apostolova T; Dzhambazov B
    Biomolecules; 2024 Oct; 14(10):. PubMed ID: 39456247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
    Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M
    Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease in natural killer cell associated gene expression as a major characteristic of the immune status in the bloodstream of colorectal cancer patients.
    Xu Y; Xu Q; Ni S; Liu F; Cai G; Wu F; Ye X; Meng X; Mougin B; Cai S; Du X
    Cancer Biol Ther; 2011 Jan; 11(2):188-95. PubMed ID: 20962596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
    Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
    J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cytokine levels and the presence of colorectal cancer.
    Yamaguchi M; Okamura S; Yamaji T; Iwasaki M; Tsugane S; Shetty V; Koizumi T
    PLoS One; 2019; 14(3):e0213602. PubMed ID: 30883594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
    Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
    Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Edrecolomab (Mo17-1A) or fluorouracil-based chemotherapy on specific immune parameters in patients with colorectal cancer. A comparative study.
    Tsavaris NB; Katsoulas HL; Kosmas C; Papalambros E; Gouveris P; Papantoniou N; Rokana S; Kosmas N; Skopeliti M; Tsitsilonis OE
    Oncology; 2004; 67(5-6):403-10. PubMed ID: 15713997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease stage prognostic indices in the early clinical screening of colorectal cancer patients.
    Pellegrini P; Berghella AM; Del Beato T; Maccarone D; Casciani CU; Adorno D
    Cancer Biother Radiopharm; 1998 Apr; 13(2):89-98. PubMed ID: 10850345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot.
    Qiu Y; Patwa TH; Xu L; Shedden K; Misek DE; Tuck M; Jin G; Ruffin MT; Turgeon DK; Synal S; Bresalier R; Marcon N; Brenner DE; Lubman DM
    J Proteome Res; 2008 Apr; 7(4):1693-703. PubMed ID: 18311904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Umbilical Cord Blood-Derived Natural Killer Cells Combined with Bevacizumab for Colorectal Cancer Treatment.
    Xu C; Liu D; Chen Z; Zhuo F; Sun H; Hu J; Li T
    Hum Gene Ther; 2019 Apr; 30(4):459-470. PubMed ID: 29914273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-33 as an early predictor of cetuximab treatment efficacy in patients with colorectal cancer.
    Zhang X; Bi K; Tu X; Zhang Q; Cao Q; Liang Y; Zeng P; Wang L; Liu T; Fang W; Diao H
    Cancer Med; 2021 Dec; 10(23):8338-8351. PubMed ID: 34664425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling of cytokines, chemokines and other soluble proteins as a potential biomarker in colorectal cancer and polyps.
    Johdi NA; Mazlan L; Sagap I; Jamal R
    Cytokine; 2017 Nov; 99():35-42. PubMed ID: 28689023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenoma.
    Henry CJ; Sedjo RL; Rozhok A; Salstrom J; Ahnen D; Levin TR; D'Agostino R; Haffner S; DeGregori J; Byers T
    BMC Cancer; 2015 Mar; 15():123. PubMed ID: 25884547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Tim‑3 expression on peripheral NK cells is correlated with pathologic TNM staging in colorectal cancer.
    Wang Y; Sun J; Gao W; Song B; Shao Q; Zhao L; Zhang Y; Wang Q; Zhang Y; Qu X
    Mol Med Rep; 2017 Jun; 15(6):3810-3818. PubMed ID: 28440449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of immature monocyte-derived dendritic cells generated from patients with colorectal cancer.
    Maciejewski R; Radej S; Furmaga J; Chrościcki A; Rudzki S; Roliński J; Wallner G
    Pol Przegl Chir; 2013 Dec; 85(12):714-20. PubMed ID: 24468592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Natural Killer Cell Activity and Colorectal Cancer in High-Risk Subjects Undergoing Colonoscopy.
    Jobin G; Rodriguez-Suarez R; Betito K
    Gastroenterology; 2017 Oct; 153(4):980-987. PubMed ID: 28625834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I--an independent prognostic factor.
    Kaminska J; Nowacki MP; Kowalska M; Rysinska A; Chwalinski M; Fuksiewicz M; Michalski W; Chechlinska M
    Tumour Biol; 2005; 26(4):186-94. PubMed ID: 16006772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationships between systemic cytokine profiles and inflammatory markers in colorectal cancer and the prognostic significance of these parameters.
    Park JW; Chang HJ; Yeo HY; Han N; Kim BC; Kong SY; Kim J; Oh JH
    Br J Cancer; 2020 Aug; 123(4):610-618. PubMed ID: 32488137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Killer Cell IFNγ Secretion is Profoundly Suppressed Following Colorectal Cancer Surgery.
    Angka L; Martel AB; Kilgour M; Jeong A; Sadiq M; de Souza CT; Baker L; Kennedy MA; Kekre N; Auer RC
    Ann Surg Oncol; 2018 Nov; 25(12):3747-3754. PubMed ID: 30187278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival.
    Sorrentino C; D'Antonio L; Fieni C; Ciummo SL; Di Carlo E
    Front Immunol; 2021; 12():778329. PubMed ID: 34975867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.